The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The Promise study: A presurgical randomized clinical trial of CE/BZA vs placebo in postmenopausal women with ductal carcinoma in situ.
 
Swati Kulkarni
No Relationships to Disclose
 
Geoffrey Greene
Stock and Other Ownership Interests - Olema Pharmaceuticals; Sermonix Pharmaceuticals
Consulting or Advisory Role - Sermonix Pharmaceuticals
Research Funding - Olema Pharmaceuticals; Sermonix Pharmaceuticals
Patents, Royalties, Other Intellectual Property - US Patent 12,023,321 B2, July 2, 2024 LASOFOXIFENE TREATMENT OF AROMATASE-RESISTANT ER+CANCER
 
Luis Blanco
No Relationships to Disclose
 
Thea Tlsty
No Relationships to Disclose
 
Philippe Gascard
No Relationships to Disclose
 
Danielle Kline
No Relationships to Disclose
 
Masha Kocherginsky
Honoraria - Bristol Myers Squibb Foundation
Patents, Royalties, Other Intellectual Property - Royalties - co-inventor on Patent 9149485, "Methods and compositions related to glucocorticoid receptor antagonists and breast cancer".
 
Yangruijue Ma
No Relationships to Disclose
 
Rebecca Aft
No Relationships to Disclose
 
Mary Ahn
No Relationships to Disclose
 
Judy Garber
Consulting or Advisory Role - Belharra Therapeutics, Inc. (I); Earli, Inc.; GV20 Therapeutics (I); Kronos Bio (I); Novartis (I)
Research Funding - Ambry Genetics; Amgen; InVitae; Novartis (I)
Other Relationship - Adrienne Helis Malvin Medical Research Foundation (I); Breast Cancer Research Foundation; Diana Helis Henry Medical Foundation (I); Facing our Risk of Cancer Empowered; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation; James P. Wilmot Foundation (I)
 
Kirstyn Brownson
Consulting or Advisory Role - Impedimed
 
Emilia Diego
No Relationships to Disclose
 
David Euhus
No Relationships to Disclose
 
Julia Tchou
No Relationships to Disclose
 
Melissa Lazar
No Relationships to Disclose
 
Michael Avram
No Relationships to Disclose
 
Lauren Schulte
No Relationships to Disclose
 
Denisha Brown
No Relationships to Disclose
 
Natalie Friedman
No Relationships to Disclose